ALBANY, N.Y.--(BUSINESS WIRE)--Transparency Market Research has announced the release of a report titled “Antibacterial Drugs Market (By Class- Aminoglycosides, B-Lactams, Tetracyclines, Sulfonamides, Quinolones/ Fluoroquinolones, Macrolides and Phenicols, and Pipeline Analysis)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.”
The report states that the antibacterial drugs market was worth US$43.55 billion in 2012 and is anticipated to grow at a 0.3% CAGR to reach US$45.09 billion by 2019.
The global antibacterial drugs market is divided into four main regions: North America, Europe, Asia-Pacific, and Rest of the World. By class, the antibacterial drugs can be categorized into quinolones/fluoroquinolones, sulfonamides, macrolides, phenicols, aminoglycosides, tetracyclines, and b-lactams.
Request Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1567
The report on the antibacterial drugs market analyzes the industry in terms of factors driving the region, local challenges, and forces of demand and supply. The report also identifies emerging markets and evaluates their potential for growth.
- Liver Diseases Therapeutics Market: http://www.transparencymarketresearch.com/liver-diseases-therapeutics.html
- Pain Management Therapeutics Market: http://www.transparencymarketresearch.com/pain-management-therapeutics.html
- Enteric Disease Testing Market: http://www.transparencymarketresearch.com/enteric-disease-testing-market.html
Asia-Pacific dominated the antibacterial drugs market in 2012, generating maximum revenue. Market projection suggests that the Asia-Pacific antibacterial drugs market will continue to maintain its lead position during the forecast period. North America was the second largest antibacterial drugs market in 2012, followed by Europe.
Key players of the antibacterial drugs market have been profiled in the report and a detailed evaluation of individual companies has been provided. Some of the leading participants of the antibacterial drugs market include Forest Laboratories, Inc., Eli Lilly and Company, Novartis AG, Pfizer, Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, AstraZeneca plc, Bayer AG, Johnson & Johnson, and Sanofi.
Browse all Pharmaceutical Reports : http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
TMR is a U.S. based market intelligence company driven by a global team of high-pedigree industry consultants, analysts, and researchers. TMR leverages its worldwide Syndicated Research, Custom Research, and Market Consulting expertise to help businesses make accurate decisions.
The company’s multi-disciplinary expertise has made it the preferred growth partner of hundreds of companies worldwide, from multibillion dollar conglomerates to emerging regional businesses. TMR’s exclusive blend of quantitative forecasting and trends analysis draws on proprietary data sources, tools, and techniques.